Engage regional and local payers and healthcare decision-makers in compliant, non-promotional scientific exchange about clinical evidence, real-world evidence, health economics, and the value of Arrowhead’s cardiometabolic RNAi therapies. Develop territory engagement plans, gather and share payer insights, deliver scientific presentations, and collaborate with Medical Affairs, Market Access, and other teams.
Engage regional and local payers and healthcare decision-makers through compliant, non-promotional scientific exchange about clinical evidence, real-world evidence, health economics, and the value of Arrowhead’s cardiometabolic RNAi portfolio. Develop territory engagement plans, deliver scientific presentations, gather payer insights, and collaborate with Medical Affairs, Market Access, and evidence teams to support access and broader payer strategy.
The Associate Director will manage a portfolio of payer and PBM accounts while serving as a strategic partner to National Account Directors to enable patient access. They will act as a centralized source of truth for formulary coverage, payer policies, and utilization management criteria while translating data into actionable insights.
The National Account Director will manage strategic relationships with Zinc and CVS Caremark to secure formulary access for Arrowhead's commercial portfolio. They will lead contract negotiations, monitor payer trends, and collaborate with cross-functional teams to support patient access.
The National Account Director will manage strategic relationships with government payers to secure formulary and coverage access for Arrowhead's commercial portfolio. They will lead contract negotiations, monitor market trends, and collaborate cross-functionally to ensure effective payer engagement and organizational alignment.
The Medical Science Liaison will engage with cardiologists and endocrinologists to provide scientific education on RNAi technology and cardiometabolic disease treatments. They will also synthesize clinical insights, support company-sponsored trials, and manage territory-specific account plans.
The Medical Science Liaison will engage with healthcare professionals to provide scientific education on RNAi technology and cardiometabolic disease states. They are responsible for synthesizing clinical insights, supporting company-sponsored trials, and managing territory-specific account plans.
